University of Southern California
USC Norris Comprehensive Cancer Center


Not logged in...


If you are a patient, please contact Keck Medical Center of USC at 800-USC-CARE.

Trial 0C-14-2


AN OPEN-LABEL, PHASE 2 BASKET STUDY OF NERATINIB IN PATIENTS WITH SOLID TUMORS WITH SOMATIC ACTIVATING HER MUTATIONS

Type: Treatment
Phase: Phase II
Status: Open to Accrual
Treatments: Chemotherapy: Systemic
Randomized: No
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  David Quinn, M.D.
Other Trial Staff:  Kristy Watkins, R.N., Alicia Bogardus, Coordinator, Cristina De Leon, Coordinator, Deborah Fridman, Coordinator, Xiomara Menendez, R.N., Jessica Levano, Coordinator, Jessica Levano, Coordinator, Jubilee Acap, R.N., Arthur Alvarez, D.M., Negeen Izadian, D.M., Cristina Lee, Coordinator, Stephanie Kim, D.M.

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3111.